New Insights Into the Treatment of Hyperlipidemia: Pharmacological Updates and Emerging Treatments
Source : https://pubmed.ncbi.nlm.nih.gov/38919858/
Cardiovascular diseases are the leading causes of global mortality and morbidity. Hyperlipidemia is a significant risk factor for atherosclerosis and subsequent cardiovascular diseases. Hyperlipidemia is characterized by imbalances in blood...
Hyperlipidemia, influenced by genetics and lifestyle, is a key modifiable risk factor for cardiovascular diseases. Effective management involves lifestyle changes, traditional medications like statins, and emerging therapies such as PCSK9 inhibitors and inclisiran. Advances in genetic research and personalized medicine are enhancing...
Share
Osteoprotegerin mediates adipogenesis in obesity
Source : https://pubmed.ncbi.nlm.nih.gov/38906326/
OPG emerges as a key regulator in mediating adipogenesis during obesity development. Targeting OPG holds promise for the prevention and treatment of obesity, as evidenced by the efficacy of electroacupuncture...
OPG emerges as a key regulator in mediating adipogenesis during obesity development. Targeting OPG holds promise for the prevention and treatment of obesity, as evidenced by the efficacy of electroacupuncture treatment in modulating OPG levels and managing obesity-related outcomes.
Share
Breaking new ground in lipid management: Insights from the 2024 American College of Cardiology Scientific Sessions
Source : https://pubmed.ncbi.nlm.nih.gov/38849020/
Breaking new ground in lipid management: Insights from the 2024 American College of Cardiology Scientific Sessions
The recent ACC meeting in Atlanta has underscored a transformative surge in the field of lipid disorders, positioning it as a rapidly advancing frontier in contemporary medicine. This pivotal moment represents a critical call to action, challenging us to address the widespread public unawareness that permeates this dominant health risk.
Share
Genetically predicted lipids mediate the association between intrahepatic cholestasis of pregnancy and cardiovascular disease
Source : https://pubmed.ncbi.nlm.nih.gov/38745758/
The results underscore the genetic predisposition of ICP to elevate CVD risk and the critical mediating role of lipid levels, emphasizing the need for vigilant lipid monitoring and early intervention...
The results underscore the genetic predisposition of ICP to elevate CVD risk and the critical mediating role of lipid levels, emphasizing the need for vigilant lipid monitoring and early intervention in individuals with ICP.
Share
This study suggests that because there is a substantial range of values of apoB for any value of LDL-C or non–HDL-C, restricting testing of apoB to those with metabolic risk factors will miss a substantial minority of individuals with discordantly elevated levels of apoB relative to LDL-C or non–HDL-C.
Share